Skip to content

Exploratory clinical study for early detection of glaucoma using novel evaluation device.

Exploratory clinical study for early detection of glaucoma using novel evaluation device. - Exploratory clinical study for early detection of glaucoma using novel evaluation device.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032230425
Enrollment
39
Registered
2023-10-26
Start date
2023-10-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects, Glaucoma, Preperimetric glaucoma glaucoma, preperimetric glaucoma

Interventions

Visual field testing with newly deveoped perimetry.

Sponsors

Akiba Ryutaro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [Healthy subject] Subject meeting all of below conditions: 1. Age between 20 and 80 years. 2. Eyes with open angle 3. Eyes with best corrected decimal visual acuity of or above 0.5 4. Eyes with refractive error of less than -6 diopters (spherical) and -3 diopters (cylinder). 5. Subject must undergo through explanation of the study, then sign the written consent form upon subject's free will. 6. Eyes without diagnosis of glaucoma or preperimetric glaucoma. [Glaucoma subject] Must meet criteria 1-5 of healthy subjects, and have eyes diagnosed as glaucoma. [Preprimetric glaucoma subject] Must meet criteria 1-5 of healyh subjects, and have eyesdiagnosed as preperimetric glaucoma.

Exclusion criteria

Exclusion criteria: 1. Subject regarded as non-qualified by doctor in chief of the clinical study. 2. Eyes with history of ocular trauma, or intraocular surgery (Except for cataract and glaucoma with no surgical complications.) 3. Eyes with underlying retinal disease, uveitis, and non-glaucomatous optic neuritis. 4. History of optic chiasm disaese or demyelinating disease that affect visual field. 5. History of cognitive disase including Parkinson's diesase, Alzheimer's disease, and cerebral infarction. 6. Eyes with poor fixation upon Humphrey visual field test.

Design outcomes

Primary

MeasureTime frame
Correlation analysis between conventional humphrey fielad analyzer and the newly developed perimetry.

Secondary

MeasureTime frame
Correlation analysis between optical coherence tomography and newly developed perimetry.

Contacts

Public ContactRyutaro Akiba

Chiba University Hospital

akiba@chiba-u.jp+81-43-226-2124

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026